Tuesday, January 9, 2018

Drug Industry Isn't Giving Up on Alzheimer's

“The mood is definitely negative on anything near-term, [but] there continues to be interest in this space,” said Mark Ginestro, a principal for health-care and life sciences strategy at KPMG in San Francisco. “It's too big of a market to ignore. People are going to continue to go after it despite the roadblocks.”.
Delivered by KPMG Today (@KPMG_TO)
Article continues here
Follow @KPMG_TO on Twitter to get latest updates